GWENDOLYN ZILINSKAS: Open Payments
NPI 1871558718 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 7 payments from 7 companies in 2025. Trend: 2023 $426 · 2024 $875 · 2025 $616
Food & beverage: $357Consulting: $260
| Company | Payments | Amount |
|---|---|---|
| KARL STORZ Endoscopy-America | 1 | $260 |
| Baxter Healthcare | 1 | $146 |
| Astellas Pharma US Inc | 1 | $135 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Blue Earth Diagnostics | 1 | $20 |
| TOLMAR, INC. | 1 | $19 |
| Tempus AI, Inc | 1 | $15 |
Products named: FLOSEAL, Xtandi, KEYTRUDA, POSLUMA, JATENZO, XT CDX.
Industry payments across TX — which companies pay providers there.
